Federal drug testing expands to methadone—but bill silent on medical use.
H.R. 7967 — Heidi’s Law · Filed by Chris Smith (R-NJ) · Introduced Mar 17, 2026 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill requires the federal government to add methadone testing to workplace drug tests for federal employees and transportation workers. It also mandates that the Department of Health and Human Services review drug-testing guidelines annually and update them to include newly identified drugs, with the Department of Transportation following suit within 60 days of each update.
Why we flagged it
The bill's core function is to broaden federal drug-testing requirements to include methadone and establish an annual review process for adding new substances. It is not a safety measure with independent justification—it is a testing mandate.
What the text implies
- Methadone is a legitimate medication for opioid use disorder and chronic pain; testing for it may penalize workers on lawful medical treatment without explicit carve-outs for prescribed use.
- Annual review mechanism (Section 4) creates open-ended authority for HHS to add any substance it 'believes should be included' without statutory constraint, potentially capturing legal substances or those with minimal safety relevance.
- No mention of how workers are notified of new substances added to testing panels or how they can challenge inclusion of medications they take lawfully.
- Transportation sector workers face cascading regulatory updates every 60 days after each HHS revision, creating compliance churn and potential for workers to be tested for substances they were unaware were added.
- Bill does not address false positives, appeals processes, or remedies for workers wrongly disqualified due to methadone testing.
Section numbers refer to the bill text the analysis read — linked under Primary records below.
Who it affects
Federal and transportation workers face expanded drug testing that may catch methadone use (including legitimate medical use) and future substances, increasing job jeopardy without corresponding worker protections or clarity on how medical use is handled. The annual update mechanism creates ongoing regulatory uncertainty for workers.
Who stands to gain
- drug testing laboratories and service providers
- workplace testing vendors
Named in the bill
Department of Health and Human Services, Department of Transportation, Federal Workplace Drug Testing Programs, Public Law 100-71, transportation employees
Where it stands
- Mar 17, 2026 — Introduced · Congress.gov: “Introduced in House”
- Mar 17, 2026 — Referred to House Committee on Transportation and Infrastructure and House Committee on Oversight and Government Reform · Congress.gov: “Referred to the Committee on Oversight and Government Reform, and in addition to the Committee on…”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
How this was measured
Analysis — Quorum's AI read the bill text published by Congress.gov (2,580 characters) on Sep 27, 2026. Section numbers in the findings refer to that text, linked below; transparency and hidden-provision scores are compared against the median of 16,222 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
As of — page rendered 2026-10-20.
“Federal drug testing expands to methadone—but bill silent on medical use.” QuorumCivic. https://share.quorumcivic.app/bill/119/hr7967 Report an error
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.